Shield Therapeutics(DE:1JS)
€0.03+0.00 (+0.00%)
DE:1JS
Shield Therapeutics Revenue
€0.03
At close:+0.00 (+0.00%)
Shield Therapeutics (1JS) Revenue
2 Followers
Shield Therapeutics Revenue
Shield Therapeutics had a revenue of 30.12M in the quarter ending Jun 30, 2026, with 6.10%. This bring the company's revenue in the last twelve months to 58.51M, Increased 14.57%. In the fiscal year ending Mar 31, 2026, Shield Therapeutics had annual revenue of 50.74M with 57.69% growth.
- Revenue (ttm)
- 58.51M
- Revenue Growth
- 31.73%
- P/S Ratio
- 0.84
- Revenue/Employee
- EUR 831,865
- Employees
- 61
- Market Cap
- EUR 42.42M
Revenue Chart
Shield Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 50.74M | 18.56M | 57.69% |
| Dec 31, 2024 | 32.18M | 15.64M | 94.57% |
| Dec 31, 2023 | 16.54M | 12.06M | 268.96% |
| Dec 31, 2022 | 4.48M | 2.96M | 195.11% |
| Jun 30, 2022 | 1.52M | -8.87M | -85.38% |
| Dec 31, 2020 | 10.39M | 9.67M | 1344.65% |
| Dec 31, 2019 | 719.00K | -11.16M | -93.95% |
| Dec 31, 2018 | 11.88M | 11.24M | 1765.15% |
| Dec 31, 2017 | 637.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.